Randomized, Double-Blind, Multicenter, Placebo-Controlled Study To Evaluate Efficacy And Safety Of Pregabalin (CI-1008) In The Treatment Of Fibromyalgia.
Phase of Trial: Phase III
Latest Information Update: 11 Nov 2015
At a glance
- Drugs Pregabalin (Primary)
- Indications Fibromyalgia; Musculoskeletal pain
- Focus Registrational; Therapeutic Use
- Sponsors Pfizer
- 03 May 2014 Results from a pooled analysis presented at the 33rd Annual Scientific Meeting of the American Pain Society.
- 03 May 2014 Post-hoc analysis presented at the 33rd Annual Scientific Meeting of the American Pain Society.
- 14 Nov 2012 Results presented at the 76th Annual Scientific Meeting of the American College of Rheumatology and the 47th Annual Meeting of the Association of Rheumatology and Health Professionals.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History